Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) EPS (Basic) (2019 - 2026)

Revolution Medicines' quarterly EPS (Basic) came in at -$2.29 in Q1 2026, down 102.65% year-on-year from $86.26 in Q1 2025, and down 21.16% quarter-over-quarter from -$1.89 in Q4 2025.

Revolution Medicines has reported EPS (Basic) for 8 years, with the latest figure at -$2.29 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 102.65% year-over-year to -$2.29; the trailing twelve-month figure through Mar 2026 stood at -$7.1 (down 77.06% YoY), and the FY2025 full-year result was -$5.95, down 66.2% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$2.29, down from -$1.89 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.61 in Q4 2022, with the low at -$2.29 in Q1 2026.
  • Average EPS (Basic) over 5 years is -$1.1, with a median of -$0.94 recorded in 2024.
  • Year-over-year, EPS (Basic) grew 15.28% in 2022 and plunged 102.65% in 2026.
  • Tracing RVMD's EPS (Basic) over 5 years: stood at -$0.61 in 2022, then slumped by 98.36% to -$1.21 in 2023, then advanced by 6.61% to -$1.13 in 2024, then slumped by 67.26% to -$1.89 in 2025, then fell by 21.16% to -$2.29 in 2026.
  • The last three EPS (Basic) figures came in at -$2.29 (Q1 2026), -$1.89 (Q4 2025), and -$1.61 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 4.06
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.55
10 Revolution Medicines 32.39 Bn 32.39 Bn - -2.29

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.29
Dec 31, 2025 -1.89
Sep 30, 2025 -1.61
Jun 30, 2025 -1.31
Mar 31, 2025 -1.13
Dec 31, 2024 -1.13
Sep 30, 2024 -0.94
Jun 30, 2024 -0.81
Mar 31, 2024 -0.70
Dec 31, 2023 -1.21
Sep 30, 2023 -0.99
Jun 30, 2023 -0.92
Mar 31, 2023 -0.72
Dec 31, 2022 -0.61
Sep 30, 2022 -0.87
Jun 30, 2022 -0.82
Mar 31, 2022 -0.78
Dec 31, 2021 -0.72
Sep 30, 2021 -0.72
Jun 30, 2021 -0.60
Mar 31, 2021 -0.53
Dec 31, 2020 -0.52
Sep 30, 2020 -0.42
Jun 30, 2020 -0.46
Mar 31, 2020 -0.74
Dec 31, 2019 -6.48
Sep 30, 2019 -6.08
Jun 30, 2019 -4.85
Mar 31, 2019 -4.84